Somatotropinoma infarction during octreotide therapy leading to bilateral cavernous sinus syndrome

Pituitary

Volumn 3, Issue 3, 2000, Pages 185-188

  Boulis, Nicholas M ^a   Noordmans, Aaron J ^a   Barkan, Ariel ^a   Hassing, Jeanne ^b   Chandler, William F ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Children's Hospital   (United States)

Author keywords

(CSS) pituitary adenoma; Acromegaly; Cavernous sinus syndrome; Octreotide

Indexed keywords

ANTIEMETIC AGENT; CABERGOLINE; GROWTH HORMONE; HYDROCORTISONE; IBUPROFEN; NARCOTIC ANALGESIC AGENT; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; VASOPRESSIN;

ACROMEGALY; ARTICLE; CASE REPORT; CAVERNOUS SINUS THROMBOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE MOVEMENT DISORDER; FEMALE; GASTROINTESTINAL SYMPTOM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; INFARCTION; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; TRANSSPHENOIDAL HYPOPHYSECTOMY; TUMOR NECROSIS; TUMOR VOLUME;

ABDUCENS NERVE; CAVERNOUS SINUS; CEREBRAL INFARCTION; CHILD; CRANIAL NERVE DISEASES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; OCTREOTIDE; OCULOMOTOR NERVE; OPHTHALMOPLEGIA; PITUITARY NEOPLASMS; SYNDROME;

EID: 0034433604     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011459927751     Document Type: Article

References (22)

1. Drug therapy: Octreotide
2. Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: Shrinkage of invasive pituitary macroadenomas and improved surgical remission rate
3. Shrinkage of inoperable adenomas in carvernous sinus with high-dose octreotide
4. Reversible shrinkage of a growth hormone-secreting pituitary adenoma by a long-acting somatostatin analogue, octreotide
5. The devlopment of dependence to an octapeptide somatostatin analog: Contribution to the study of somatostatin analgesia
6. Analgesic effect of a somatostatin analog, SMS 201-995, on headache associated with tumor of the hypophysis
7. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors
8. Inhibition of angiogenesis by somoatostatin and somatostatin-like compounds is structurally dependent
9. Octreotide dependency and headache: A case report
10. Analgesis effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case report
11. Anonymous. Consensus statement: Benefits versus risks of medical therapy for acromegaly
12. Gallstones during octreotide therapy
13. Evidence supporting surgery as treatment of choice for acromegaly
14. Traumatic carotid-cavernous fistula
15. Pituitary apoplexy manifested during a bromocriptine test in a patient with growth hormone- and prolactin-producing pituitary adenoma
16. Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly
17. Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995)
18. Sclerotherapy with or without octreotide for acute variceal bleeding
19. Hemodynamic effects of 8-day DL-028 and octreotide administration in rats with portal hypertension
20. Phosphatase activity in the arterial wall after balloon injury: Effect of somatostatin analog octreotide
21. Pituitary apoplexy following closed head trauma
22. Intracranial arterial vasospasm associated with pituitary apoplexy after head trauma